Mesenchymal stromal cell therapy for COVID-19 acute respiratory distress syndrome: a double-blind randomised controlled trial
María Esther Martínez-Muñoz, Concepción Payares‐Herrera, I. Lipperheide, Rosa Malo de Molina, Isabel Salcedo, Rosalía Alonso, Trinidad Martín-Donaire, Rocío Montejano, Rocío Zafra, Miguel García-Berciano, Andrea Trisán-Alonso, Manuel Pérez-Torres, António Ramos, Piedad Ussetti, Juan José Álvarez Rubio, C. Avendaño, Rafael F. Duarte
Topics & Concepts
MedicineARDSDiscontinuationClinical endpointClinical trialAdverse effectPlaceboInternal medicineRandomized controlled trialLungPathologyAlternative medicineMesenchymal stem cell researchRespiratory Support and MechanismsLong-Term Effects of COVID-19